Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis

• Главные авторы: Teresa Barcina Lacosta (Автор), Arnold G. Vulto (Автор), Isabelle Huys (Автор), Steven Simoens (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: The level of competition achieved following biosimilars market availability varies by country, care setting and molecule. Hence, biosimilars contribution to attaining price reductions and extended access to treatments can also vary.Objective: The aim of this study is to capture market dy...